{"id":"NCT02171130","sponsor":"Eli Lilly and Company","briefTitle":"Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia","officialTitle":"A Multiple Center, Open Label, Prospective, Observational Study to Evaluate the Effectiveness and Ease-of-Use of AMG504-1 Administered in the Home or Work Environments for Treating Episodes of Hypoglycemia in Patients With Type 1 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2015-08","completion":"2015-08","firstPosted":"2014-06-24","resultsPosted":"2019-10-15","lastUpdate":"2019-10-15"},"enrollment":129,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypoglycemia","Diabetes Mellitus","Drug-Specific Antibodies"],"interventions":[{"type":"DRUG","name":"Nasal Glucagon","otherNames":["Dry-Mist Nasal Glucagon","AMG504-1","LY900018"]}],"arms":[{"label":"Nasal glucagon","type":"EXPERIMENTAL"}],"summary":"Up to two hundred (200) adult participants with type 1 diabetes (T1D) aged 18 to 75 years will be selected for inclusion in the study. The target is to obtain treatment response and user-experience data following use of nasal glucagon (AMG504-1) in treating episodes of hypoglycemia. The population will be enriched to include participants who suffer from impaired hypoglycemia awareness.","primaryOutcome":{"measure":"Percentage of Participants Awakening or Returning to a Normal Status Within 30 Minutes Following Studied Drug of Administration","timeFrame":"Within 30 minutes after each drug administration for an episode of hypoglycemia","effectByArm":[{"arm":"Nasal Glucagon","deltaMin":95.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":2},"locations":{"siteCount":9,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":87},"commonTop":["Nasal Irritation","Headache","Nausea","Lacrimation increased","Vomiting"]}}